To view this email as a web page, click here.
 
From our partner site Managed Healthcare Executive
Ovarian cancer could be next application for CAR T-cell therapy
While CAR T-cell therapy has been proven to work for liquid—or blood—cancers, the challenge has been to apply this technology to solid tumors.
Read more
 
New treatment for advanced kidney cancer approved
FDA expanded the indication on cabozantinib (Cabometyx) to treat patients with advanced renal cell carcinoma (RCC).
Read more
 
FDA approves breakthrough cancer gene test
FDA approved a new cancer biomarker test that can detect genetic mutations in 324 genes and 2 genomic signatures in tumors.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.